Cargando…

Glucose promotes breast cancer aggression and reduces metformin efficacy

Metformin treatment has been associated with a decrease in breast cancer risk and improved survival. Metformin induces complex cellular changes, resulting in decreased tumor cell proliferation, reduction of stem cells, and apoptosis. Using a carcinogen-induced rodent model of mammary tumorigenesis,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wahdan-Alaswad, Reema, Fan, Zeying, Edgerton, Susan M, Liu, Bolin, Deng, Xin-Sheng, Arnadottir, Sigrid Salling, Richer, Jennifer K, Anderson, Steven M, Thor, Ann D
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Landes Bioscience 2013
Materias:	Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3905068/ https://www.ncbi.nlm.nih.gov/pubmed/24107633 http://dx.doi.org/10.4161/cc.26641

Ejemplares similares

Metformin Targets Glucose Metabolism in Triple Negative Breast Cancer
por: Wahdan-Alaswad, RS, et al.
Publicado: (2018)

Targeted lapatinib anti-HER2/ErbB2 therapy resistance in breast cancer: opportunities to overcome a difficult problem
por: Wahdan-Alaswad, Reema, et al.
Publicado: (2020)

Thyroid Hormone and Estrogen Promote Endocrine Resistance, Proliferation, Dedifferentiation, and Cancer Stem Cells in Steroid Receptor-Positive Breast Cancers
por: Wahdan-Alaswad, Reema S, et al.
Publicado: (2021)

“Sister” miRNAs in cancers
por: Wahdan-Alaswad, Reema, et al.
Publicado: (2013)

Hic-5 Controls BMP4 Responses in Prostate Cancer Cells through Interacting with Smads 1, 5 and 8
por: Shola, Dorjee T.N., et al.
Publicado: (2011)

Metformin Treatment Reduces CRC Aggressiveness in a Glucose-Independent Manner: An In Vitro and Ex Vivo Study
por: Boutaud, Marie, et al.
Publicado: (2023)

Critical Role of a Survivin/TGF-β/mTORC1 Axis in IGF-I-Mediated Growth of Prostate Epithelial Cells
por: Song, Kyung, et al.
Publicado: (2013)

The erbB3- and IGF-1 receptor-initiated signaling pathways exhibit distinct effects on lapatinib sensitivity against trastuzumab-resistant breast cancer cells
por: Lyu, Hui, et al.
Publicado: (2015)

Downregulation of miR-342 is associated with tamoxifen resistant breast tumors
por: Cittelly, Diana M, et al.
Publicado: (2010)

Transcriptomic and proteomic intra-tumor heterogeneity of colorectal cancer varies depending on tumor location within the colorectum
por: Árnadóttir, Sigrid Salling, et al.
Publicado: (2020)

Functional interaction between mouse erbB3 and wild-type rat c-neu in transgenic mouse mammary tumor cells
por: Kim, Aeree, et al.
Publicado: (2005)

Upregulation of endogenous TRAIL-elicited apoptosis is essential for metformin-mediated antitumor activity against TNBC and NSCLC
por: Liu, Shuang, et al.
Publicado: (2021)

Therapeutic targeting of erbB3 with MM-121/SAR256212 enhances antitumor activity of paclitaxel against erbB2-overexpressing breast cancer
por: Wang, Shuiliang, et al.
Publicado: (2013)

Genome-wide functional genetic screen with the anticancer agent AMPI-109 identifies PRL-3 as an oncogenic driver in triple-negative breast cancers
por: Gari, Hamid H., et al.
Publicado: (2016)

Ganetespib targets multiple levels of the receptor tyrosine kinase signaling cascade and preferentially inhibits ErbB2-overexpressing breast cancer cells
por: Lee, Harry, et al.
Publicado: (2018)

Activation of cancerous inhibitor of PP2A (CIP2A) contributes to lapatinib resistance through induction of CIP2A-Akt feedback loop in ErbB2-positive breast cancer cells
por: Zhao, Ming, et al.
Publicado: (2017)

Metformin inhibits stromal aromatase expression and tumor progression in a rodent model of postmenopausal breast cancer
por: Giles, Erin D., et al.
Publicado: (2018)

Metformin Mitigated Obesity-Driven Cancer Aggressiveness in Tumor-Bearing Mice
por: Chen, Chun-Jung, et al.
Publicado: (2022)

Metformin reduces airway glucose permeability and hyperglycaemia-induced Staphylococcus aureus load independently of effects on blood glucose
por: Garnett, James P, et al.
Publicado: (2013)

Adding Saxagliptin to Metformin Extended Release (XR) or Uptitration of Metformin XR: Efficacy on Daily Glucose Measures
por: Neutel, Joel M., et al.
Publicado: (2013)

50 Metformin versus Insulin: Glucose Control and Safety in Burn Patients
por: Hallman, Taylor, et al.
Publicado: (2023)

Metformin and Cancer Glucose Metabolism: At the Bench or at the Bedside?
por: Marini, Cecilia, et al.
Publicado: (2021)

Metformin and Chemoprevention: Potential for Heart-Healthy Targeting of Biologically Aggressive Breast Cancer
por: Jones, Veronica C., et al.
Publicado: (2020)

Metformin reduces liver glucose production by inhibition of fructose-1-6-bisphosphatase
por: Hunter, Roger W., et al.
Publicado: (2018)

Metformin increases glucose uptake and acts renoprotectively by reducing SHIP2 activity
por: Polianskyte-Prause, Zydrune, et al.
Publicado: (2019)

Metformin acutely lowers blood glucose levels by inhibition of intestinal glucose transport
por: Horakova, Olga, et al.
Publicado: (2019)

Metformin is synthetically lethal with glucose withdrawal in cancer cells
por: Khurana, Ashwani, et al.
Publicado: (2012)

Glucose-responsive Insulinoma with Insulin Hypersecretion Suppressed by Metformin
por: Hamano, Kunihisa, et al.
Publicado: (2019)

Metformin Targets Foxo1 to Control Glucose Homeostasis
por: Guo, Xiaoqin, et al.
Publicado: (2021)

Is Brain Insulin Action Relevant to the Control of Plasma Glucose in Humans?
por: Edgerton, Dale S., et al.
Publicado: (2015)

Metformin reduces glucose intolerance caused by rapamycin treatment in genetically heterogeneous female mice
por: Weiss, Roxanne, et al.
Publicado: (2018)

Metformin lowers glucose 6-phosphate in hepatocytes by activation of glycolysis downstream of glucose phosphorylation
por: Moonira, Tabassum, et al.
Publicado: (2020)

Metformin increases fasting glucose clearance and endogenous glucose production in non-diabetic individuals
por: McCreight, Laura J., et al.
Publicado: (2019)

Anti-tumor effects of everolimus and metformin are complementary and glucose-dependent in breast cancer cells
por: Ariaans, Gerke, et al.
Publicado: (2017)

Effects of exercise and metformin on the prevention of glucose intolerance: a comparative study
por: Molena-Fernandes, C., et al.
Publicado: (2015)

Environmental concentrations of metformin exposure affect aggressive behavior in the Siamese fighting fish, Betta splendens
por: MacLaren, Ronald David, et al.
Publicado: (2018)

Metformin acts as a dual glucose regulator in mouse brain
por: Jin, Bo-Yeong, et al.
Publicado: (2023)

Loss of miR-200c: A Marker of Aggressiveness and Chemoresistance in Female Reproductive Cancers
por: Cochrane, Dawn R., et al.
Publicado: (2010)

Oral metformin transiently lowers post-prandial glucose response by reducing the apical expression of sodium-glucose co-transporter 1 in enterocytes
por: Zubiaga, Lorea, et al.
Publicado: (2023)

Estimation of salivary tumor necrosis factor-alpha in chronic and aggressive periodontitis patients
por: Varghese, Sheeja S., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_ps1jjtf9j7hmu7p2r7nfvu4k02